These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1690260)

  • 1. Drug-induced revertants of adenovirus-transformed cells: retransformation by 5-azacytidine without reactivation of E1a.
    Weber JM; Sircar S; Fleurent J; Hamel M
    J Gen Virol; 1990 Mar; 71 ( Pt 3)():585-91. PubMed ID: 1690260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivation of a methylation-silenced gene in adenovirus-transformed cells by 5-azacytidine or by E1A trans activation.
    Knust B; Brüggemann U; Doerfler W
    J Virol; 1989 Aug; 63(8):3519-24. PubMed ID: 2473219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-level beta 1 protein kinase C expression in cloned rat embryo fibroblast cells enhances transformation induced by the adenovirus type 5 E1A gene.
    Su ZZ; Duigou GJ; Fisher PB
    Mol Carcinog; 1991; 4(4):328-37. PubMed ID: 1831366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functions of adenovirus E1A.
    Berk AJ
    Cancer Surv; 1986; 5(2):367-87. PubMed ID: 2946406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ovine adenovirus vector lacks transforming ability in cells that are transformed by AD5 E1A/B sequences.
    Xu ZZ; Nevels M; MacAvoy ES; Lockett LJ; Curiel D; Dobner T; Both GW
    Virology; 2000 Apr; 270(1):162-72. PubMed ID: 10772988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wild-type adenovirus type 5 transforming genes function as transdominant suppressors of oncogenesis in mutant adenovirus type 5 transformed rat embryo fibroblast cells.
    Su ZZ; Leon JA; Jiang H; Austin VN; Zimmer SG; Fisher PB
    Cancer Res; 1993 Apr; 53(8):1929-38. PubMed ID: 8385576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of integrated adenovirus E1A and E1B genes in transformed human cells by phorbol ester tumor promoters.
    Carter T; James C; Chan E; Greene B
    Cancer Res; 1987 Feb; 47(3):803-8. PubMed ID: 2948635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the E1a gene of adenovirus type 5 alter the tumorigenic properties of transformed cloned rat embryo fibroblast cells.
    Babiss LE; Liaw WS; Zimmer SG; Godman GC; Ginsberg HS; Fisher PB
    Proc Natl Acad Sci U S A; 1986 Apr; 83(7):2167-71. PubMed ID: 2938185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus E1A gene autorepression: revertants of an E1A promoter mutation encode altered E1A proteins.
    Larsen PL; Tibbetts C
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8185-9. PubMed ID: 2960973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E1A products of adenoviruses reduce the expression of cellular proliferation-associated genes.
    Timmers HT; De Wit D; Bos JL; Van der Eb AJ
    Oncogene Res; 1988; 3(1):67-76. PubMed ID: 2974528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus type 12 tumour antigen synthesis differs during infection of permissive and non-permissive cells.
    Lucher LA
    J Gen Virol; 1990 Mar; 71 ( Pt 3)():579-83. PubMed ID: 2138209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficiency of adenovirus transformation of rodent cells is inversely related to the rate of viral E1A gene expression.
    Adami GR; Babiss LE
    J Virol; 1990 Jul; 64(7):3427-36. PubMed ID: 2141089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different adenovirus E1A-controlled properties of transformed cells require different levels of E1A expression.
    Vaessen RT; Houweling A; van der Eb AJ
    Gene; 1987; 54(2-3):247-54. PubMed ID: 2820846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-terminal domain of the adenovirus E1A oncogene product is required for induction of cytotoxic T lymphocytes and tumor-specific transplantation immunity.
    Urbanelli D; Sawada Y; Raskova J; Jones NC; Shenk T; Raska K
    Virology; 1989 Dec; 173(2):607-14. PubMed ID: 2531954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to retransformation by adenovirus but not by heterologous oncogenes in an E1-positive transformation revertant cell line may be mediated by a cellular function.
    Sircar S; Rodrigues M; Weber JM
    Oncogene; 1988 Dec; 3(6):725-8. PubMed ID: 2577877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functions of the adenovirus E1B tumour antigens.
    Stillman B
    Cancer Surv; 1986; 5(2):389-404. PubMed ID: 2946407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The amino-terminal region of the adenovirus serotype 5 E1a protein performs two separate functions when expressed in primary baby rat kidney cells.
    Smith DH; Ziff EB
    Mol Cell Biol; 1988 Sep; 8(9):3882-90. PubMed ID: 2975754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor mediated cytolysis requires the adenovirus E1a protein but not the transformed phenotype.
    Rodrigues M; Dion P; Sircar S; Weber JM
    Virus Res; 1990 Mar; 15(3):231-6. PubMed ID: 2140484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of viral and cellular gene expression during progression and suppression of the transformed phenotype in type 5 adenovirus-transformed rat embryo cells.
    Duigou GJ; Su ZZ; Babiss LE; Driscoll B; Fung YK; Fisher PB
    Oncogene; 1991 Oct; 6(10):1813-24. PubMed ID: 1923506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the adenovirus E1A oncogene during cell transformation is sufficient to induce susceptibility to lysis by host inflammatory cells.
    Cook JL; Walker TA; Lewis AM; Ruley HE; Graham FL; Pilder SH
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6965-9. PubMed ID: 2944117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.